iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionStifel Financial Corp
Latest Disclosed Ownership157,318 shares
Latest Disclosed Value $ 26,564,604
Stifel Financial Corp reports 1.22% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 157,318 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $26,564,604 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 155,420 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 1.22% during the quarter. The current value of the position is $20,616,524 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 157,318 1,898 1.22 26,565 1.27 0.0244
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 155,420 52,530 51.05 26,231 76.59 0.0236
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 102,890 -9,984 -8.85 14,855 4.02 0.0136
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 112,874 -21,064 -15.73 14,281 -16.65 0.0139
2025-05-14 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 133,938 -5,898 -4.22 17,132 -7.33 0.0182
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 139,836 -3,871 -2.69 18,489 -11.65 0.0193
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 143,707 -2,269 -1.55 20,925 4.43 0.0219
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 145,976 -1,625 -1.10 20,038 -1.07 0.0225
2024-05-14 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 147,601 9,704 7.04 20,256 8.11 0.0231
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 137,897 14,457 11.71 18,736 24.10 0.0236
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 123,440 2,219 1.83 15,098 -1.92 0.0212
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 121,221 -709 -0.58 15,393 -2.28 0.0211
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 121,930 -28,990 -19.21 15,752 -20.52 0.0226
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 150,920 21,053 16.21 19,817 30.44 0.0297
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 129,867 2,771 2.18 15,192 1.61 0.0249
2022-08-15 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 127,096 -11,731 -8.45 14,952 -17.36 0.0234
2022-05-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 138,827 13,329 10.62 18,092 -5.55 0.0247
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 125,498 -3,981 -3.07 19,156 -8.51 0.0253
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 129,479 5,959 4.82 20,937 3.56 0.0307
2021-08-13 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 123,520 7,126 6.12 20,217 15.35 0.0303
2021-05-14 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 116,394 -110,321 -48.66 17,526 -48.97 0.0289
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 226,715 112,038 97.70 34,347 121.17 0.0613
2020-11-16 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 114,677 -7,068 -5.81 15,530 -6.68 0.0319
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 121,745 26,918 28.39 16,642 63.20 0.0383
2020-05-14 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 94,827 2,813 3.06 10,197 -7.84 0.0282
2020-02-13 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 92,014 -713 -0.77 11,065 20.39 0.0231
2019-11-19 2019-09-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 92,727 -11,026 -10.63 9,191 -18.89 0.0234
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 92,791 -10,962 9,196 5,154.8189
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 103,753 -4,383 -4.05 11,331 -6.31 0.0292
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 108,136 5,925 5.80 12,094 22.67 0.0342
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 102,211 17,051 20.02 9,859 -4.90 0.0319
2018-11-13 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 85,160 11,354 15.38 10,367 28.07 0.0297
2018-08-14 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 73,806 -1,352 -1.80 8,095 1.01 0.0248
2018-05-11 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 75,158 4,328 6.11 8,014 5.85 0.0253
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 70,830 45,740 182.30 7,571 -9.45 0.0240
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 25,090 511 2.08 8,361 9.54 0.0290
2017-08-14 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 24,579 4,366 21.60 7,633 28.72 0.0283
2017-05-10 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 20,213 -2,264 -10.07 5,930 -1.00 0.0230
2017-02-16 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 22,477 570 2.60 5,990 -5.54 0.0254
2016-11-15 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 21,907 -3,823 -14.86 6,341 -4.26 0.0285
2016-08-17 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 25,730 7,958 44.78 6,623 42.95 0.0306
2016-05-16 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 17,772 1,194 7.20 4,633 -17.46 0.0247
2016-03-21 2015-12-31 13F/A-2 ISHARES TR NASDQ BIOTEC ETF 464287556 16,578 3,736 29.09 5,613 44.07 0.0292
2016-02-26 2015-12-31 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 16,552 -26 5,604 0.0293
2016-02-16 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 16,512 5,840
2015-11-16 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 12,842 -2,199 -14.62 3,896 -29.48 0.0219
2015-08-17 2015-06-30 13F/A-1 ISHARES TR NASDQ BIOTEC ETF 464287556 15,041 9 0.06 5,525 7.01 0.0286
2015-08-17 2015-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 12,677 4,669
2015-05-14 2015-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 15,032 4,198 38.75 5,163 57.07 0.0283
2015-02-13 2014-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 10,834 3,510 47.92 3,287 64.02 0.0183
2014-11-13 2014-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 7,324 -2,757 -27.35 2,004 -22.66 0.0176
2014-08-14 2014-06-30 13F ISHARES NASDQ BIOTEC ETF 464287556 10,081 -3,101 -23.52 2,591 -16.85 0.0233
2014-05-15 2014-03-31 13F ISHARES NASDQ BIOTEC ETF 464287556 13,182 13,182 3,116 0.0298
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.